Previous Next Low-value Care Gilead’s Covid Drug Win Could Clog Pipeline for Other Treatments Abstract: The future of Covid-19 treatment is cloudier after the FDA approved Gilead Sciences Inc.'s remdesivir, the first virus treatment to get full authorization in the U.S. Publication: Bloomberg Date Published: October 23, 2020 Author(s): Jacquie Lee View This Resource